CELH
Celsius Holdings, Inc.
CELH has the edge over IH overall, supported by stronger fundamentals and stronger valuation.
IH
iHuman Inc.
IH has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
IH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Strong |
IH's balance sheet is currently strong, and its profitability and cash flow are stable, but its revenue is under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
IH PE Valuation
IH has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
IH Forward outlook
There aren't enough analyst estimates for IH to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
IH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.33 | -78% |
| Q1 2026 | $1.03 | -28% |
| Q4 2025 | $1.34 | -2.2% |
| Q3 2025 | $1.49 | +3.5% |
| Q2 2025 | $1.53 | -16% |
| Q1 2025 | $1.43 | -31% |
| Q4 2024 | $1.37 | -45% |
| Q3 2024 | $1.44 | -43% |
IH's earnings per share have fallen from their peak: $0.33 over the past year, against $2.54 in late 2023.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over IH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over IH on profitability, with a higher operating margin.
IH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $26M | -13% |
| Q1 2026 | $27.4M | -13% |
| Q4 2025 | $28.6M | -18% |
| Q3 2025 | $30.9M | -14% |
| Q2 2025 | $30M | -6.9% |
| Q1 2025 | $31.6M | -10% |
| Q4 2024 | $34.9M | -7.1% |
| Q3 2024 | $35.9M | -8.4% |
IH's revenue has slid since its 2023 peak: $26M last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -12% | -22 points |
| Q1 2026 | -5.5% | -16 points |
| Q4 2025 | 4.7% | -1.7 points |
| Q3 2025 | 8.1% | -0.6 points |
| Q2 2025 | 9.7% | +1 points |
| Q1 2025 | 10% | +2.8 points |
| Q4 2024 | 6.4% | -2.3 points |
| Q3 2024 | 8.7% | -6.8 points |
IH's operating margin was −12% last quarter, down 22 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over IH on cash flow, with more consistent year-over-year improvement.
IH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
IH's free cash flow was $0 over the past year, against $0 the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
IH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.7% | -389K shares |
| 1 year | -4.4% | -472K shares |
| 3 years | -6.6% | -722K shares |
| 5 years | -6.5% | -713K shares |
| Available history | -4.1% | -442K shares |
IH has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
IH hasn't bought back shares in the past year.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
IH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -87.8x | Net Cash |
| Q1 2026 | -5.4x | Net Cash |
| Q4 2025 | -11.2x | Net Cash |
| Q3 2025 | -4.5x | Net Cash |
| Q2 2025 | -5.0x | Net Cash |
| Q1 2025 | -9.5x | Net Cash |
| Q4 2024 | -9.5x | Net Cash |
| Q3 2024 | -5.3x | Net Cash |
IH has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
IH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.5 | Oversold |
| Stochastic | 7.2 | Oversold |
IH's weekly RSI is 24 (oversold) and its Stochastic is 7 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
IH PE vs Consumer Defensive Sector
IH has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over IH on trend strength, trading above more of its moving averages.
IH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.13 | 11% below |
| 20 week MA | $1.24 | 19% below |
| 50 week MA | $1.58 | 36% below |
| 100 week MA | $1.99 | 49% below |
| 200 week MA | $2.23 | 55% below |
IH is in a downtrend: it's below all five of its weekly moving averages, and 55% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over IH on returns for 2026, with the stronger performance.
IH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.0 | $20.3 | +27% |
| 2021 | $20.3 | $3.02 | -85% |
| 2022 | $3.02 | $2.49 | -18% |
| 2023 | $2.49 | $3.07 | +23% |
| 2024 | $3.07 | $1.72 | -44% |
| 2025 | $1.72 | $2.19 | +27% |
| 2026 YTD | $2.19 | $1.01 | -54% |
IH has finished lower in three of the last six years. It's down 54% so far in 2026.